ABOS stock results show that Acumen Pharmaceuticals beat analyst estimates for earnings per share the first quarter of ...
Operator VCs have a long history in Silicon Valley. Still, their adoption is less widespread in Europe and Africa: only 8% of ...
Congress states that the legal accusations against Kanhaiya Kumar are influenced by political motives, with no formal charges ...
Daniel O'Connell; Chief Executive Officer, Director; Acumen Pharmaceuticals Inc W. Matthew Zuga; Chief Financial Officer, Chief Business Officer; Acumen Pharmaceuticals Inc Eric Siemers; Chief Medical ...
The results build upon Acumen’s prior presentations at the AD/PD™ 2024 Annual Meeting and positive topline data first announced in July 2023, highlighting sabirnetug as the first humanized monoclonal ...
In a report released yesterday, Jason Zemansky from Bank of America Securities maintained a Buy rating on Acumen Pharmaceuticals (ABOS – ...
Acumen Pharmaceuticals has dosed the first patient in ALTITUDE-AD, a Phase II trial designed to evaluate the clinical ...
Real Madrid claimed a record-extending 36th LaLiga title on Saturday after Girona's 4-2 thrashing of local rivals Barcelona ...
Sixteen high school students from across the province showcased their business acumen and personal finance prowess in the ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of ...
Acumen Media launches this month’s edition of the highly anticipated ‘Innovators & Disruptors’ documentary series, going live on CBS News and Acumen Stories. This series showcases pioneering ...